Saeed Motahari

Saeed Motahari discloses dealings in Insys Therapeutics, Inc. to SEC (Form 4). We count 8 filings; the first trade dates from 16 May 2017 and the latest from 25 January 2019.

No open-market sale appears; the market trades are 3 purchases worth €144k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 5 share grants.

In size, the median ticket on the buying side is €49k. On 1 out of 3 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 23 April 2019: a share grant, in Insys Therapeutics, Inc. The clock since the last published purchase (10 August 2017) now reads 3,362 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 42 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.